We have an updated report [Version - 2023] available. Kindly sign up to get the sample of the report.

Global Animal Antibiotics and Antimicrobials Market

Market Overview:
The global Animal Antibiotics and Antimicrobialsmarket was valued at USD 3.76billion in 2016 and is projected to reach USD 5.60billionby 2025, growing at a CAGR of 4.54% from 2017 to 2025.
Animal Antibiotics are in high demand due to increasing breeding practices and increment in Animal Product requirement. The market is expected to grow during the forecast period at a high rate.

Sample Infographics:



Market Dynamics:
1. Market Drivers
1.1 Rising Demand for Animal-Derived Food Products
1.2 Increasing Incidence of Zoonotic Diseases
1.3 Implementation of Regulations for Preventing the Spread of Animal Diseases
1.4 Rising Demand for Pet Insurance and Growing Animal Health Expenditure
2. Market Restraints
2.1 Dearth of New Antibiotics
2.2 Growing Resistance to Antimicrobials and Antibiotics
2.3 Routine Prophylactic Use of Antibiotics Being Replaced By Good Husbandry and Hygiene Practices

Market Segmentation:
1. By Mode Of Delivery:
1.1 Premixes
1.2 Oral Powders
1.3 Oral Solutions
1.4 Injections
1.5 Other Modes of Delivery

2. By Product:
2.1 Tetracyclines
2.2 Penicillins
2.3 Sulfonamides
2.4 Macrolides
2.5 Aminoglycosides
2.6 Lincosamides
2.7 Fluoroquinolones
2.8 Cephalosporins
2.9 Other Antimicrobials and Antibiotics

3. By Type of Animal:
3.1 Food Producing
3.1.1 Cattle
3.1.2 Pigs
3.1.3 Poultry
3.1.4 Sheep and Goats
3.1.5 Other Food-Producing Animals
3.2 Companion
3.2.1 Dogs
3.2.2 Cats
3.2.3 Horses
3.2.4 Other Companion Animals

4. By Region:
4.1 North America (U.S., Canada, Mexico)
4.2 Europe (Germany, UK, France, Rest of Europe)
4.3 Asia Pacific (China, India, Japan, Rest of Asia Pacific)
4.4 Latin America (Brazil, Argentina, Rest of Latin America)
4.5 Middle East & Africa

Competitive Landscape:
The major players in the market are as follows:
1. Zoetis, Inc.
2. BoehringerIngelheim GmbH
3. Eli Lilly and Company
4. Merck & Co., Inc.
5. Bayer AG
6. Sanofi
7. CevaSanteAnimale
8. Virbac
9. Vetoquinol S.A.
10. Dechra Pharmaceuticals PLC
These major players have adopted various organic as well as inorganic growth strategies such as mergers & acquisitions, new product launches, expansions, agreements, joint ventures, partnerships, and others to strengthen their position in this market.

RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE:
Research study on the Animal Antibiotics and Antimicrobialsmarketwas performed in five phases which include Secondary research, Primary research, subject matter expert advice, quality check and final review.
The market data was analyzed and forecasted using market statistical and coherent models. Also market shares and key trends were taken into consideration while making the report. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis.

To know more about the Research Methodology of Verified Market Intelligence and other aspects of the research study, kindly get in touch with our sales team.

1 INTRODUCTION OF GLOBAL ANIMAL ANTIBIOTICS AND ANTIMICROBIALSMARKET
1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE
3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources

4 GLOBAL ANIMAL ANTIBIOTICS AND ANTIMICROBIALSMARKETOUTLOOK
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
4.5 Regulatory Framework

5 GLOBAL ANIMAL ANTIBIOTICS AND ANTIMICROBIALS MARKET, BY MODE OF DELIVERY:
5.1 Overview
5.2 Premixes
5.3 Oral Powders
5.4 Oral Solutions
5.5 Injections
5.6 Other Modes of Delivery

6 GLOBAL ANIMAL ANTIBIOTICS AND ANTIMICROBIALS MARKET, BY PRODUCT:
6.1 Overview
6.2 Tetracyclines
6.3 Penicillins
6.4 Sulfonamides
6.5 Macrolides
6.6 Aminoglycosides
6.7 Lincosamides
6.8 Fluoroquinolones
6.9 Cephalosporins
6.10 Other Antimicrobials and Antibiotics

7 GLOBAL ANIMAL ANTIBIOTICS AND ANTIMICROBIALS MARKET, BY TYPE OF ANIMAL:
7.1 Overview
7.2 Food Producing
7.2.1 Cattle
7.2.2 Pigs
7.2.3 Poultry
7.2.4 Sheep and Goats
7.2.5 Other Food-Producing Animals
7.3 Companion
7.3.1 Dogs
7.3.2 Cats
7.3.3 Horses
7.3.4 Other Companion Animals

8 GLOBAL ANIMAL ANTIBIOTICS AND ANTIMICROBIALSMARKET, BY GEOGRAPHY
8.1 Overview
8.2 North AmericaRegional Market Estimates and Forecasts, 2012 - 2025
8.2.1 U.S.
8.2.2 Canada
8.2.3 Mexico
8.3 EuropeRegional Market Estimates and Forecasts, 2012 - 2025
8.3.1 Germany
8.3.2 U.K.
8.3.3 France
8.3.4 Rest of Europe
8.4 Asia PacificRegional Market Estimates and Forecasts, 2012 - 2025
8.4.1 China
8.4.2 Japan
8.4.3 India
8.4.4 Rest of Asia Pacific
8.5 Latin AmericaRegional Market Estimates and Forecasts, 2012 - 2025
8.5.1 Brazil
8.5.2 Argentina
8.6 Rest of the WorldRegional Market Estimates and Forecasts, 2012 - 2025

9 GLOBAL ANIMAL ANTIBIOTICS AND ANTIMICROBIALSMARKETCOMPETITIVE LANDSCAPE
9.1 Overview
9.2 Company Market Share
9.3 Vendor Landscape
9.4 Key Development Strategies

10 COMPANY PROFILES
10.1 Zoetis, Inc.
10.1.1 Overview
10.1.2 Financial Performance
10.1.3 Product Outlook
10.1.4 Key Developments

10.2 BoehringerIngelheim GmbH
10.2.1 Overview
10.2.2 Financial Performance
10.2.3 Product Outlook
10.2.4 Key Developments

10.3 Eli Lilly and Company
10.3.1 Overview
10.3.2 Financial Performance
10.3.3 Product Outlook
10.3.4 Key Developments

10.4 Merck & Co., Inc.
10.4.1 Overview
10.4.2 Financial Performance
10.4.3 Product Outlook
10.4.4 Key Developments

10.5 Bayer AG
10.5.1 Overview
10.5.2 Financial Performance
10.5.3 Product Outlook
10.5.4 Key Developments

10.6 Sanofi
10.6.1 Overview
10.6.2 Financial Performance
10.6.3 Product Outlook
10.6.4 Key Developments

10.7 CevaSanteAnimale
10.7.1 Overview
10.7.2 Financial Performance
10.7.3 Product Outlook
10.7.4 Key Developments

10.8 Virbac
10.8.1 Overview
10.8.2 Financial Performance
10.8.3 Product Outlook
10.8.4 Key Developments

10.9 Vetoquinol S.A.
10.9.1 Overview
10.9.2 Financial Performance
10.9.3 Product Outlook
10.9.4 Key Development

10.10 Dechra Pharmaceuticals PLC
10.10.1 Overview
10.10.2 Financial Performance
10.10.3 Product Outlook
10.10.4 Key Development

11 Appendix
11.1 Related Reports

Choose License Type

Happy To Assist You

Contact Images

We will be happy to help you find what you need. Please call us or write to us:

Frequently Asked Questions

This report incorporates the analysis of factors that augments the market growth. Report presents competitive landscape of the global market. This also provides the scope of different segments and applications that can potentially influence the market in the future. The analysis is based on current market trends and historic growth data. It includes detailed market segmentation, regional analysis, and competitive landscape of the industry.
The report efficiently evaluates the current market size and provides industry forecast. The market was valued at xxx Million US$ in 2019, and is expected to grow at a CAGR of xx% during the period 2020-2027.
The report efficiently evaluates the current market size and provides forecast for the industry in terms of Value (US$ Mn) and Volume (Thousands Units).
Market is segmented by:
  • Product Types
  • Drug Class
  • Indication
  • Applications
  • Services Types
  • End-users
  • Distribution channel
  • Regions
The report share key insights on the following:
  • Current market size
  • Market forecast
  • Market opportunities
  • Key drivers
  • Restraints
  • Pipeline Analysis
  • Incidence Rate
  • Epidemiology Analysis
  • Prevalence rate
  • Regulatory scenario
  • Industry trend
  • Pestle Analysis
  • Porter’s Analysis
  • New product approvals/launch
  • Promotion and marketing initiatives
  • Pricing analysis
  • Export-import analysis
  • Trade analysis
  • Competitive landscape
It helps the businesses in making investments decisions.
Customization helps the organization to gain insight on specific segments and regions of interest. Thus, WMR offers tailored report information based on business requirement in order to take strategic calls.
Contact us

mapicon
Sales Office (U.S.):
Worldwide Market Reports, 533 Airport Boulevard, Suite 400, Burlingame, CA 94010, United States

mapicon+1-415-871-0703

mapicon
Asia Pacific Intelligence Center (India):
Worldwide Market Reports, 403, 4th Floor, Bremen Business Center, Aundh, Pune, Maharashtra 411007, India.

Newsletter

Want us to send you latest updates of the current trends, insights, and more, signup to our newsletter (for alerts, special offers, and discounts).


Secure Payment By:
paymenticon

This website is secured Origin CA certificate on the server, Comodo, Firewall and Verified Sitelock Malware Protection

secureimg

© 2024 Worldwide Market Reports. All Rights Reserved